NFASC and irritable bowel syndrome: These findings suggest that altered neuroimmune architecture, involving specific NF subtypes and their crosstalk with MCs, may contribute to IBS pathophysiology and symptoms, including abdominal pain, and could represent potential therapeutic targets.